Technology

AgeX

$1.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-5.15%) Today
$0.00 (0.00%) As of 12:34 AM UTC after-hours

Why Robinhood?

You can buy or sell AgeX and other stocks, options, and ETFs commission-free!

About AGE

AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. The listed name for AGE is AgeX Therapeutics, Inc.

CEO
Michael D. West
Employees
17
Headquarters
Alameda, California
Founded
2017
Market Cap
62.20M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
230.11K
High Today
$1.97
Low Today
$1.76
Open Price
$1.97
Volume
363.77K
52 Week High
$3.93
52 Week Low
$0.666

Collections

AGE Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, After Hours

You May Also Like

NP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure